Vir Biotechnology Inc at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) Transcript
Welcome back everyone to the fourth annual H.C. Wainwright HBV conference. My name is Patrick Trucchio, I'm a senior healthcare analyst at H.C. Wainwright. And it's my pleasure to introduce our next presenter, Phil Pang, CMO of Vir Biotechnology, a commercial stage immunology company focused on combining immunologic insight with cutting-edge technologies to treat and prevent serious infectious diseases.
Questions & Answers
So maybe we can start first with some background on Vir, including founding of the company and what makes this platform unique and differentiated in the area of infectious disease.
Thank you, Patrick. Hello to everyone. And again, thank you for this opportunity, Patrick, to speak at this -- at the H.C. Wainwright congress here.
So a little bit about Vir. Vir was founded as an
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |